Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Milbar Laboratories, Inc.
FDA Inspection
•Milbar Laboratories, Inc.•May 17, 2016

Milbar Laboratories, Inc. – FDA Inspection, May 17, 2016

Record Details

This FDA Inspection record concerns Milbar Laboratories, Inc., with an inspection on May 17, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Milbar Laboratories, Inc.
Inspection Date
May 17, 2016
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 672d063e-b986-45da-a31c-526a590a28bf

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
971848
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 211.58Buildings not maintained in good state of repair
  2. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.198(a)Complaint Handling Procedure
  5. 21 CFR 211.186(a)Written procedures followed
  6. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  7. 21 CFR 211.100(a)Absence of Written Procedures
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
  10. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Milbar Laboratories, Inc.

7
DateClassificationOfficeProject area
November 7, 2024VAINew England District OfficeDrug Quality Assurance
January 2, 2024NAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
September 27, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 11, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 27, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Milbar Laboratories, Inc.
  • FDA Inspection 1253807 - 2024-11-07
  • FDA Inspection 1231023 - 2024-01-02
  • FDA Inspection 1180954 - 2022-09-27
  • FDA Inspection 1107471 - 2019-10-11
  • FDA Inspection 1036724 - 2017-12-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Milbar Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.